Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Prof. Dr. phil. nat. Katharina Lückerath

E-Mail
Katharina.Lueckerath@uk-essen.de

Funktionen

  • Wiss. Mitarbeiterinnen/Mitarbeiter, Klinik für Nuklearmedizin

Aktuelle Veranstaltungen

Keine aktuellen Veranstaltungen.

Vergangene Veranstaltungen (max. 10)

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Storey, Claire M.; Altai, Mohamed; Lückerath, Katharina; Zedan, Wahed; Zhu, Henan; Breuer, Lara; Trajkovic-Arsic, Marija; Park, Julie; Hasson, Abbie; Siveke, Jens; Abou, Diane; Marks, Haley; Ulmert, Enna; Ridley, Alexander; Safi, Marcella; Lamminmäki, Urpo; Yuen, Constance; Geres, Susanne; Mao, Liqun; Cheng, Michael; Subudhi, Sumit K.; Siddiqui, Bilal A.; Federman, Noah; Czernin, Johannes; Herrmann, Ken; Bentolila, Laurent; Yang, Xia; Graeber, Thomas G.; Damoiseaux, Robert; Thorek, Daniel; Ulmert, David
    Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance
    In: Signal Transduction and Targeted Therapy, Jg. 10, 2025, Nr. 1, 319
    DOI (Open Access)
  • Pouget, Jean-Pierre; Gabina, Pablo Minguez; Herrmann, Ken; Deandreis, Desirée; Konijnenberg, Mark; Taieb, David; van Leeuwen, Fijs W. B.; Kurth, Jens; Eberlein, Uta; Lassmann, Michael; Lückerath, Katharina; EANM Radiobiology Working Group
    EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? : Part I: back to the basics of absorbed dose–response and threshold absorbed doses
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2025, Nr. 3, S. 1210 – 1222
    DOI (Open Access)
  • Altai, Mohamed; Nagy, Ábel; Granit, Pauline; Zedan, Wahed; Cerezo-Magaña, Myriam; Park, Julie; Lückerath, Katharina; Geres, Susanne; Sydoff, Marie; Thorek, Daniel L.J.; Westerlund, Kristina; Ulmert, David; Karlström, Amelie Eriksson
    Optimizing peptide nucleic acid-based pretargeting for enhanced targeted radionuclide therapy
    In: Journal of Controlled Release, Jg. 381, 2025, 113551
    DOI (Open Access)
  • Pabst, Kim M.; Mei, Riccardo; Lückerath, Katharina; Hadaschik, Boris; Kesch, Claudia; Rawitzer, Josefine; Kessler, Lukas; Bodensieck, Luisa S.; Hamacher, Rainer; Pomykala, Kelsey L.; Fanti, Stefano; Herrmann, Ken; Fendler, Wolfgang
    Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [⁶⁸Ga]Ga-/[¹⁸F]F-PSMA-11/-1007, [⁶⁸Ga]Ga-FAPI-46 and 2-[¹⁸F]FDG PET/CT : a pilot study
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2024, Nr. 1, S. 342 – 353
    DOI (Open Access)
  • Taddio, Marco F.; Doshi, Suraj; Masri, Marwan; Jeanjean, Pauline; Hikmat, Firas; Gerlach, Alana; Nyiranshuti, Lea; Rosser, Ethan W.; Schaue, Dorthe; Besserer-Offroy, Elie; Carlucci, Giuseppe; Radu, Caius G.; Czernin, Johannes; Lückerath, Katharina; Mona, Christine E.
    Evaluating [²²⁵Ac]Ac-FAPI-46 for the treatment of soft-tissue sarcoma in mice
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 51, 2024, Nr. 13, S. 4026 – 4037
    DOI (Open Access)
  • Nagy, Ábel; Ulmert, David; Zedan, Wahed; Storey, Claire M.; Park, Julie; Geres, Susanne; Lückerath, Katharina; Sjöström, Kjell; Westin, Hadis; Peekhaus, Norbert; Thorek, Daniel LJ.; Karlström, Amelie Eriksson; Altai, Mohamed
    Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeutics
    In: European Journal of Medicinal Chemistry, Jg. 280, 2024, 116927
    DOI (Open Access)
  • Costa, Pedro Fragoso; Püllen, Lukas; Kesch, Claudia; Krafft, Ulrich; Tschirdewahn, Stephan; Moraitis, Alexandros; Radtke, Jan Philipp; Ting, Saskia; Nader, Michael; Wosniack, Jasmin; Kersting, David; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang; Hadaschik, Boris; Darr, Christopher
    18F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in Men
    In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 4, S. 598 – 604
    DOI (Open Access)
  • Handke, Analena; Kesch, Claudia; Fendler, Wolfgang; Telli, Tugce; Liu, Yang; Hakansson, Alexander; Davicioni, Elai; Hughes, Jason; Song, Hong; Lückerath, Katharina; Herrmann, Ken; Hadaschik, Boris; Seifert, Robert
    Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy
    In: Journal for ImmunoTherapy of Cancer, Jg. 11, 2023, Nr. 10, e007354
    DOI (Open Access)
  • Lückerath, Katharina; Trajkovic-Arsic, Marija; Mona, Christine E.
    Fibroblast Activation Protein Inhibitor Theranostics : Preclinical Combination Treatment
    In: PET Clinics, Jg. 18, 2023, Nr. 3, S. 409 – 418
    DOI
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Ingenwerth, Marc; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lückerath, Katharina; Kasper, Stefan; Nader, Michael; Schildhaus, Hans-Ulrich; Kesch, Claudia; von Tresckow, Bastian; Hanoun, Christine; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Niedergethmann, Marco; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P.
    Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
    In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 5, S. 711 – 716
    DOI (Open Access)
  • Küper, Alina; Blanc-Durand, Paul; Gafita, Andrei; Kersting, David; Fendler, Wolfgang; Seibold, Constantin; Moraitis, Alexandros; Lückerath, Katharina; James, Michelle L.; Seifert, Robert
    Is There a Role of Artificial Intelligence in Preclinical Imaging?
    In: Seminars in Nuclear Medicine, Jg. 53, 2023, Nr. 5, S. 687 – 693
    DOI
  • Demmert, Tristan T.; Maric, Ines; Pomykala, Kelsey L.; Lueckerath, Katharina; Siveke, Jens; Schaarschmidt, Benedikt M.; Hamacher, Rainer; Herrmann, Ken; Fendler, Wolfgang P.
    Novel ⁶⁸Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine-Related Pitfalls
    In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 3, S. 368 – 371
    DOI (Open Access)
  • Demmert, Tristan T.; Pomykala, Kelsey L.; Lanzafame, Helena; Pabst, Kim M.; Lueckerath, Katharina; Siveke, Jens; Umutlu, Lale; Hautzel, Hubertus; Hamacher, Rainer; Herrmann, Ken; Fendler, Wolfgang P.
    Oncologic Staging with ⁶⁸Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than ¹⁸F-FDG PET/CT
    In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 12, S. 1906 – 1909
    DOI (Open Access)
  • Civan, Caner; Kasper, Stefan; Berliner, Christoph; Fragoso-Costa, Pedro; Grünwald, Viktor; Pogorzelski, Michael; Schaarschmidt, Benedikt Michael; Lang, Stephan; Kersting, David; Nader, Michael; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang P.; Weber, Manuel
    PSMA-Directed Imaging and Therapy of Salivary Gland Tumors : A Single-Center Retrospective Study
    In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 3, S. 372 – 378
    DOI (Open Access)
  • Storey, Claire M.; Altai, Mohamed; Bicak, Mesude; Veach, Darren R.; Lückerath, Katharina; Adrian, Gabriel; McDevitt, Michael R.; Kalidindi, Teja; Park, Julie E.; Herrmann, Ken; Abou, Diane; Zedan, Wahed; Peekhaus, Norbert; Klein, Robert J.; Damoiseaux, Robert; Larson, Steven M.; Lilja, Hans; Thorek, Daniel; Ulmert, David
    Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
    In: Molecular Cancer Research, Jg. 21, 2023, Nr. 4, S. 307 – 315
    DOI, Online Volltext (Open Access)
  • Pabst, Kim M.; Trajkovic-Arsic, Marija; Cheung, Phyllis F Y; Ballke, Simone; Steiger, Katja; Bartel, Timo; Schaarschmidt, Benedikt M.; Milosevic, Aleksandar; Seifert, Robert; Nader, Michael; Kessler, Lukas; Siveke, Jens T.; Lückerath, Katharina; Kasper, Stefan; Herrmann, Ken; Hirmas, Nader; Schmidt, Hartmut; Hamacher, Rainer; Fendler, Wolfgang
    Superior Tumor Detection for ⁶⁸Ga-FAPI-46 Versus ¹⁸F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
    In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 7, S. 1049 – 1055
    DOI (Open Access)
  • Meyer, Catherine; Stuparu, Andreea; Lückerath, Katharina; Calais, Jeremie; Czernin, Johannes; Slavik, Roger; Dahlbom, Magnus
    Tandem Isotope Therapy with ²²⁵Ac- and ¹⁷⁷Lu-PSMA-617 in a Murine Model of Prostate Cancer
    In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 11, S. 1772 – 1778
    DOI (Open Access)
  • Klose, Jasmin M.; Wosniack, Jasmin; Iking, Janette; Staniszewska, Magdalena; Zarrad, Fadi; Trajkovic-Arsic, Marija; Herrmann, Ken; Costa, Pedro Fragoso; Lückerath, Katharina; Fendler, Wolfgang
    Administration Routes for SSTR-/PSMA- and FAP-Directed Theranostic Radioligands in Mice
    In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 9, S. 1357 – 1363
    DOI, Online Volltext (Open Access)
  • Meyer, Catherine; Prasad, Vikas; Stuparu, Andreea; Kletting, Peter; Glatting, Gerhard; Miksch, Jonathan; Solbach, Christoph; Lückerath, Katharina; Nyiranshuti, Lea; Zhu, Shaojun; Czernin, Johannes; Beer, Ambros J.; Slavik, Roger; Calais, Jeremie; Dahlbom, Magnus
    Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225
    In: EJNMMI Research, Jg. 12, 2022, Nr. 1, 65
    DOI (Open Access)
  • Kessler, Lukas; Ferdinandus, Justin; Hirmas, Nader; Zarrad, Fadi; Nader, Michael; Kersting, David; Weber, Manuel; Kazek, Sandra; Sraieb, Miriam; Hamacher, Rainer; Lückerath, Katharina; Umutlu, Lale; Fendler, Wolfgang; Rischpler, Christoph
    Pitfalls and Common Findings in ⁶⁸Ga-FAPI PET : A Pictorial Analysis
    In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 6, S. 890 – 896
    DOI (Open Access)
  • Ferdinandus, Justin; Fendler, Wolfgang; Lückerath, Katharina; Berliner, Christoph; Kurzidem, Sabine; Hadaschik, Eva; Klode, Joachim; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Herrmann, Ken; Becker, Jürgen; Ugurel, Selma
    Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
    In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 3, S. 396 – 398
    DOI (Open Access)
  • Fendler, Wolfgang P.; Pabst, Kim M.; Kessler, Lukas; Fragoso Costa, Pedro; Ferdinandus, Justin; Weber, Manuel; Lippert, Maria; Lückerath, Katharina; Umutlu, Lale; Kostbade, Karina; Mavroeidi, Ilektra A.; Schuler, Martin; Ahrens, Marit; Rischpler, Christoph; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens T.; Hamacher, Rainer
    Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
    In: Clinical Cancer Research, Jg. 28, 2022, Nr. 19, S. 4346 – 4353
    DOI (Open Access)
  • Staniszewska, Magdalena; Iking, Janette; Lückerath, Katharina; Hadaschik, Boris; Herrmann, Ken; Ferdinandus, Justin; Fendler, Wolfgang
    Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer
    In: Nuclear Medicine and Biology, Jg. 96-97, 2021, S. 101 – 111
    DOI (Open Access)
  • Staniszewska, Magdalena; Fragoso Costa, Pedro; Eiber, Matthias; Klose, Jasmin M.; Wosniack, Jasmin; Reis, Henning; Szarvas, Tibor; Hadaschik, Boris; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang; Iking, Janette
    Enzalutamide enhances psma expression of psma-low prostate cancer
    In: International Journal of Molecular Sciences (IJMS), Jg. 22, 2021, Nr. 14, 7431
    DOI, Online Volltext (Open Access)
  • Iking, Janette; Staniszewska, Magdalena; Kessler, Lukas; Klose, Jasmin M.; Lückerath, Katharina; Fendler, Wolfgang; Herrmann, Ken; Rischpler, Christoph
    Imaging Inflammation with Positron Emission Tomography
    In: Biomedicines, Jg. 9, 2021, Nr. 2, S. 212
    DOI, Online Volltext (Open Access)
  • Czernin, Johannes; Current, Kyle; Mona, Christine E.; Nyiranshuti, Lea; Hikmat, Firas; Radu, Caius G.; Lückerath, Katharina
    Immune-Checkpoint Blockade Enhances ²²⁵Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer
    In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 2, S. 228 – 231
    DOI (Open Access)
  • Stuparu, Andreea D.; Capri, Joseph R.; Meyer, Catherine; Le, Thuc M.; Evans-Axelsson, Susan L.; Current, Kyle; Lennox, Mark; Mona, Christine E.; Fendler, Wolfgang; Calais, Jérémie; Eiber, Matthias; Dahlbom, Magnus; Czernin, Johannes; Radu, Caius G.; Lückerath, Katharina; Slavik, Roger
    Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer
    In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 7, S. 989 – 995
    DOI (Open Access)
  • Veach, Darren R.; Storey, Claire M.; Lückerath, Katharina; Braun, Katharina; von Bodman, Christian; Lamminmäki, Urpo; Kalidindi, Teja; Strand, Sven-Erik; Strand, Joanna; Altai, Mohamed; Damoiseaux, Robert; Zanzonico, Pat; Benabdallah, Nadia; Pankov, Dmitry; Scher, Howard I.; Scardino, Peter; Larson, Steven M.; Lilja, Hans; McDevitt, Michael R.; Thorek, Daniel L.J.; Ulmert, David
    PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
    In: Clinical Cancer Research, Jg. 27, 2021, Nr. 7, S. 2050 – 2060
    DOI (Open Access)
  • Bicak, Mesude; Lückerath, Katharina; Kalidindi, Teja; Phelps, Michael E.; Strand, Sven-Erik; Morris, Michael J.; Radu, Caius G.; Damoiseaux, Robert; Peltola, Mari T.; Peekhaus, Norbert; Ho, Austin; Veach, Darren; Malmborg Hager, Ann-Christin; Larson, Steven M.; Lilja, Hans; McDevitt, Michael R.; Klein, Robert J.; Ulmert, David
    Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
    In: Proceedings of the National Academy of Sciences of the United States of America (PNAS), Jg. 117, 2020, Nr. 26, S. 15172 – 15181
    DOI, Online Volltext (Open Access)
  • Current, Kyle; Meyer, Catherine; Magyar, Clara E.; Mona, Christine E.; Almajano, Joel; Slavik, Roger; Stuparu, Andreea D.; Cheng, Chloe; Dawson, David W.; Radu, Caius G.; Czernin, Johannes; Lückerath, Katharina
    Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity
    In: Clinical Cancer Research, Jg. 26, 2020, Nr. 12, S. 2946 – 2955
    DOI, Online Volltext (Open Access)
  • Stuparu, Andreea D.; Meyer, Catherine A.L.; Evans-Axelsson, Susan L.; Lückerath, Katharina; Wei, Liu H.; Kim, Woosuk; Poddar, Soumya; Mona, Christine E.; Dahlbom, Magnus; Girgis, Mark D.; Radu, Caius G.; Czernin, Johannes; Slavik, Roger
    Targeted alpha therapy in a systemic mouse model of prostate cancer : A feasibility study
    In: Theranostics, Jg. 10, 2020, Nr. 6, S. 2612 – 2620
    DOI (Open Access)
  • Lapa, Constantin; Lückerath, Katharina; Kircher, Stefan; Hänscheid, Heribert; Grigoleit, Götz U.; Rosenwald, Andreas; Stolzenburg, Antje; Kropf, Saskia; Einsele, Hermann; Wester, Hans-Jürgen; Buck, Andreas K.; Kortüm, Klaus M.; Schirbel, Andreas
    Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy
    In: British Journal of Haematology, Jg. 184, 2019, Nr. 3, S. 440 – 443
    DOI, Online Volltext (Open Access)
  • Lückerath, Katharina; Stuparu, Andreea D.; Wei, Liu; Kim, Woosuk; Radu, Caius G.; Mona, Christine E.; Calais, Jeremie; Rettig, Matthew; Reiter, Robert E.; Czernin, Johannes; Slavik, Roger; Herrmann, Ken; Eiber, Matthias; Fendler, Wolfgang P.
    Detection Threshold and Reproducibility of ⁶⁸Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer
    In: Journal of Nuclear Medicine (JNM), Jg. 59, 2018, Nr. 9, S. 1392 – 1397
    DOI (Open Access)
  • Lückerath, Katharina; Wei, Liu; Fendler, Wolfgang; Evans-Axelsson, Susan; Stuparu, Andreea D.; Slavik, Roger; Mona, Christine E.; Calais, Jeremie; Rettig, Matthew; Reiter, Robert E.; Herrmann, Ken; Radu, Caius G.; Czernin, Johannes; Eiber, Matthias
    Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
    In: EJNMMI Research, Jg. 8, 2018, Nr. 1, 96
    DOI (Open Access)
  • Lapa, Constantin; Herrmann, Ken; Schirbel, Andreas; Hänscheid, Heribert; Lückerath, Katharina; Schottelius, Margret; Kircher, Malte; Werner, Rudolf A.; Schreder, Martin; Samnick, Samuel; Kropf, Saskia; Knop, Stefan; Buck, Andreas K.; Einsele, Hermann; Wester, Hans-Juergen; Kortüm, K. Martin
    CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma
    In: Theranostics, Jg. 7, 2017, Nr. 6, S. 1589 – 1597
    DOI (Open Access)
  • Fendler, Wolfgang; Stuparu, Andreea D.; Evans-Axelsson, Susan; Lückerath, Katharina; Wei, Liu; Kim, Woosuk; Poddar, Soumya; Said, Jonathan; Radu, Caius G.; Eiber, Matthias; Czernin, Johannes; Slavik, Roger; Herrmann, Ken
    Establishing 177Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer
    In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 11, S. 1786 – 1792
    DOI (Open Access)
  • Lapa, Constantin; Kircher, Stefan; Schirbel, Andreas; Rosenwald, Andreas; Kropf, Saskia; Pelzer, Theo; Walles, Thorsten; Buck, Andreas K.; Weber, Wolfgang A.; Wester, Hans-Juergen; Herrmann, Ken; Lückerath, Katharina
    Targeting CXCR4 with [68Ga]Pentixafor : A suitable theranostic approach in pleural mesothelioma?
    In: OncoTarget, Jg. 8, 2017, Nr. 57, S. 96732 – 96737
    DOI (Open Access)
  • Lapa, Constantin; Schreder, Martin; Schirbel, Andreas; Samnick, Samuel; Kortüm, Klaus Martin; Herrmann, Ken; Kropf, Saskia; Einsele, Herrmann; Buck, Andreas K; Wester, Hans-Jürgen; Knop, Stefan; Lückerath, Katharina
    [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values
    In: Theranostics, Jg. 7, 2017, Nr. 1, S. 205 – 212
    DOI (Open Access)
  • Lapa, Constantin; Garcia-Velloso, Maria J; Lückerath, Katharina; Samnick, Samuel; Schreder, Martin; Otero, Paula Rodriguez; Schmid, Jan-Stefan; Herrmann, Ken; Knop, Stefan; Buck, Andreas K; Einsele, Hermann; San-Miguel, Jesus; Kortüm, Klaus Martin
    ¹¹C-Methionine-PET in Multiple Myeloma : A Combined Study from Two Different Institutions
    In: Theranostics, Jg. 7, 2017, Nr. 11, S. 2956 – 2964
    DOI (Open Access)
  • Herrmann, Ken; Schottelius, Margret; Lapa, Constantin; Osl, Theresa; Poschenrieder, Andreas; Hänscheid, Heribert; Lückerath, Katharina; Schreder, Martin; Bluemel, Christina; Knott, Markus; Keller, Ulrich; Schirbel, Andreas; Samnick, Samuel; Lassmann, Michael; Kropf, Saskia; Buck, Andreas K.; Einsele, Hermann; Wester, Hans-Juergen; Knop, Stefan
    First-in-human experience of CXCR4-directed endoradiotherapy with ¹⁷⁷Lu-and ⁹⁰Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra-and extramedullary disease
    In: Journal of Nuclear Medicine (JNM), Jg. 57, 2016, Nr. 2, S. 248 – 251
    DOI
  • Lapa, Constantin; Knop, Stefan; Schreder, Martin; Rudelius, Martina; Knott, Markus; Jörg, Gerhard; Samnick, Samuel; Herrmann, Ken; Buck, Andreas K.; Einsele, Hermann; Lückerath, Katharina
    ¹¹C-methionine-PET in multiple myeloma : Correlation with clinical parameters and bone marrow involvement
    In: Theranostics, Jg. 6, 2016, Nr. 2, S. 254 – 261
    DOI (Open Access)
  • Philipp-Abbrederis, Kathrin; Herrmann, Ken; Knop, Stefan; Schottelius, Margret; Eiber, Matthias; Lückerath, Katharina; Pietschmann, Elke; Habringer, Stefan; Gerngroß, Carlos; Franke, Katharina; Rudelius, Martina; Schirbel, Andreas; Lapa, Constantin; Schwamborn, Kristina; Steidle, Sabine; Hartmann, Elena; Rosenwald, Andreas; Kropf, Saskia; Beer, Ambros J.; Peschel, Christian; Einsele, Hermann; Buck, Andreas K.; Schwaiger, Markus; Götze, Katharina; Wester, Hans-Jürgen; Keller, Ulrich
    In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
    In: EMBO Molecular Medicine, Jg. 7, 2015, Nr. 4, S. 477 – 487
    DOI (Open Access)
  • Lückerath, Katharina; Lapa, Constantin; Albert, Christa; Herrmann, Ken; Jörg, Gerhard; Samnick, Samuel; Einsele, Herrmann; Knop, Stefan; Buck, Andreas K.
    ¹¹C-Methionine-PET : A novel and sensitive tool for monitoring of early response to treatment in multiple myeloma
    In: OncoTarget, Jg. 6, 2015, Nr. 10, S. 8418 – 8429
    DOI (Open Access)
  • Lapa, Constantin; Lückerath, Katharina; Malzahn, Uwe; Samnick, Samuel; Einsele, Herrmann; Buck, Andreas K.; Herrmann, Ken; Knop, Stefan
    ¹⁸FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
    In: OncoTarget, Jg. 5, 2014, Nr. 17, S. 7381 – 7391
    DOI (Open Access)
  • Lückerath, Katharina; Lapa, Constantin; Spahmann, Annika; Jörg, Gerhard; Samnick, Samuel; Rosenwald, Andreas; Einsele, Herrmann; Knop, Stefan; Buck, Andreas K.
    Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biology
    In: PLoS ONE, Jg. 8, 2013, Nr. 12, S. e84840
    DOI (Open Access)
  • Lückerath, Katharina; Kirkin, Vladimir; Melzer, Inga Maria; Thalheimer, Frederic B.; Siele, Dagmar; Milani, Wiebke; Adler, Thure; Aguilar-Pimentel, Antonio; Horsch, Marion; Michel, Geert; Beckers, Johannes; Busch, Dirk H.; Ollert, Markus; Gailus-Durner, Valerie; Fuchs, Helmut; De Angelis, Martin Hrabě; Staal, Frank J. T.; Rajalingam, Krishnaraj; Hueber, Anne-Odile; Strobl, Lothar J.; Zimber-Strobl, Ursula; Zörnig, Martin
    Immune modulation by Fas ligand reverse signaling : Lymphocyte proliferation is attenuated by the intracellular Fas ligand domain
    In: Blood, Jg. 117, 2011, Nr. 2, S. 519 – 529
    DOI
  • Kirkin, Vladimir; Cahuzac, Nathalie; Guardiola-Serrano, Francisca; Huault, Sébastien; Lückerath, Katharina; Friedmann, Elena Imre; Novac, Natalia; Wels, Winfried S.; Martoglio, Bruno; Hueber, Anne Odile; Zörnig, Martin
    The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells
    In: Cell Death and Differentiation, Jg. 14, 2007, Nr. 9, S. 1678 – 1687
    DOI (Open Access)

    • Vorworte / Nachworte

  • Krafft, Ulrich; Hadaschik, Boris; Lückerath, Katharina; Herrmann, Ken
    A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?
    In: European Urology. Amsterdam: Elsevier, Jg. 85, 2024, Nr. 3, S. 227 – 228
    DOI

    • Abstracts

  • Handke, A.; Kesch, Claudia; Fendler, Wolfgang; Telli, Tugce; Liu, Y.; Hakansson, A.; Davicioni, E.; Hughes, J.; Song, H.; Lückerath, Katharina; Herrmann, Ken; Hadaschik, Boris; Seifert, Robert
    Analysing the Tumour Transcriptome of Prostate Cancer to Predict Efficacy of Lu-PSMA Therapy
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S180
    DOI
  • Louis, B.; Taddio, M.; Rashid, K.; Abt, E.; Rosser, E.; Le, T.; Lückerath, Katharina; Radu, C.; Czernin, J.; Mona, C.
    Enhancing PSMA-RLT efficacy with STING agonist in syngeneic models of prostate cancer
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S446
    DOI
  • Pabst, K. M.; Fendler, Wolfgang P.; Hadaschik, Boris; Kesch, C.; Hirmas, N.; Kessler, Lukas; Grünwald, Viktor; Hamacher, R.; Nader, M.; Berliner, C.; Umutlu, Lale; Püllen, Lukas; Herrmann, Ken; Lückerath, Katharina; Castellucci, P.; Fanti, S.; Mei, R.
    FAPI, PSMA and FDG PET/CT in patients with advanced metastatic castration-resistant prostate cancer (mCRPC) : a triple tracer comparison
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S118 – S119
    DOI (Open Access)
  • Civan, C.; Kasper, Stefan; Berliner, C.; Fragoso-Costa, Pedro; Grünwald, Viktor; Pogorzelski, M.; Schaarschmidt, B. M.; Lang, Stephan; Kersting, David; Nader, M.; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang P.; Weber, Manuel
    PSMA-directed imaging and therapy of salivary gland tumors : a single-center retrospective study
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S229
    DOI (Open Access)
  • Hamacher, R.W.; Pabst, K.M.; Kessler, Lukas; Costa, Pedro Fragoso; Ferdinandus, J.; Weber, Manuel; Lippert, M.; Lückerath, Katharina; Hirmas, N.; Kostbade, K.; Mavroeidi, I.A.; Schuler, Martin H. H.; Ahrens, M.; Rischpler, Christoph; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens T.; Fendler, Wolfgang P.
    Safety and efficacy of [90Y]Y-FAPI-46 radioligand therapy in patients with advanced sarcomas and other cancer entities
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 33, 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1231 – S1232
    DOI (Open Access)
  • Hirmas, N.; Ingenwerth, M.; Sraieb, Miriam; Kessler, Lukas; Pabst, K. M.; Lanzafame, H.; Lückerath, Katharina; Kasper, Stefan; Nader, M.; Schildhaus, Hans-Ulrich; Hadaschik, Boris; Grünwald, Viktor; von Tresckow, Bastian; Hanoun, Christine; Aigner, Clemens; Glas, Martin; Herrmann, Ken; Siveke, Jens T.; Hamacher, R.; Fendler, Wolfgang P.
    Target Expression and FAP-Directed Tumour Imaging in a Large, Single-Centre PET Database of 324 Patients and 21 Tumour Entities
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S119 – S120
    DOI (Open Access)